46 results on '"Heuze-Vourc'h, Nathalie"'
Search Results
2. Synergy between Lactobacillus murinus and anti-PcrV antibody delivered in the airways to boost protection against Pseudomonas aeruginosa
3. Pulmonary Delivery of Antibody for the Treatment of Respiratory Diseases
4. The proteolytic airway environment associated with pneumonia acts as a barrier for treatment with anti-infective antibodies
5. Influence of mesh nebulizer characteristics on aerosol delivery in non-human primates
6. Inhalable Nanofitin demonstrates high neutralization of SARS-CoV-2 virus via direct application in respiratory tract
7. Mucosal administration of anti-bacterial antibodies provide long-term cross-protection against Pseudomonas aeruginosa respiratory infection
8. Inhaled IgG1 antibodies: The buffering system is an important driver of stability during mesh-nebulization
9. Protein stability during nebulization: Mind the collection step!
10. Interleukin-7 protects against bacterial respiratory infection by promoting IL-17A-producing innate T-cell response
11. Intra-tracheal amikacin spray delivery in healthy mechanically ventilated piglets
12. In a murine model of acute lung infection, airway administration of a therapeutic antibody confers greater protection than parenteral administration
13. Tetrafunctional Block Copolymers Promote Lung Gene Transfer in Newborn Piglets
14. Prolonged pharmacological inhibition of cathepsin C results in elimination of neutrophil serine proteases
15. Development of a drug delivery system for efficient alveolar delivery of a neutralizing monoclonal antibody to treat pulmonary intoxication to ricin
16. Neutrophilic Cathepsin C Is Maturated by a Multistep Proteolytic Process and Secreted by Activated Cells during Inflammatory Lung Diseases
17. Beneficial role of overexpression of TFPI-2 on tumour progression in human small cell lung cancer
18. Monitoring of tumour progression using bioluminescence imaging and computed tomography scanning in a nude mouse orthotopic model of human small cell lung cancer
19. Kallikrein-related Peptidase 12 Hydrolyzes Matricellular Proteins of the CCN Family and Modifies Interactions of CCN1 and CCN5 with Growth Factors
20. Effect of the oligodendrocyte myelin glycoprotein (OMgp) on the expansion and neuronal differentiation of rat neural stem cells
21. Pressurized Metered Dose Inhaler Aerosol Delivery Within Nasal High-Flow Circuits: A Bench Study
22. Immune Checkpoint and Anti-Angiogenic Antibodies for the Treatment of Non-Small Cell Lung Cancer in the European Union and United States
23. Innovative preclinical models for pulmonary drug delivery research
24. IL-4 regulates COX-2 and PGE 2 production in human non-small cell lung cancer
25. IL-20, an anti-angiogenic cytokine that inhibits COX-2 expression
26. Multifaceted roles of cyclooxygenase-2 in lung cancer
27. Cyclooxygenase-2-Dependent Expression of Survivin in Non-small Cell Lung Cancer*
28. Innovative preclinical models for pulmonary drug delivery research
29. Flexible CMUT for Vibrating Mesh Nebulize
30. Exploring the fate of inhaled monoclonal antibody in the lung parenchyma by microdialysis
31. Therapeutic monoclonal antibodies for respiratory diseases: Current challenges and perspectives, March 31 - April 1, 2016, Tours, France.
32. Therapeutic monoclonal antibodies for respiratory diseases: Current challenges and perspectives, March 31 – April 1, 2016, Tours, France
33. Increment in Drug Loading on an Antibody–Drug Conjugate Increases Its Binding to the Human Neonatal Fc Receptor in Vitro
34. Development of monoclonal antibodies to human kallikrein-related peptidase 6 (KLK6) and their use in an immunofluorometric assay for free KLK6
35. Extracellular catalase activity protects cysteine cathepsins from inactivation by hydrogen peroxide
36. Nébulisation chez l’adulte sous oxygénothérapie nasale à haut débit humidifié
37. IL-4 regulates COX-2 and PGE2 production in human non-small cell lung cancer
38. Cyclooxygenase-2-Dependent Activation of Signal Transducer and Activator of Transcription 3 by Interleukin-6 in Non–Small Cell Lung Cancer
39. Cyclooxygenase-2 Modulates the Insulin-Like Growth Factor Axis in Non–Small-Cell Lung Cancer
40. COX‐2‐dependent stabilization of survivin in non‐small cell lung cancer
41. Benign lower limb amyotrophy due to TARDBP mutation or post-polio syndrome?
42. P3-031: Antitumour antibodies delivered through airways in lung cancer
43. COX-2-dependent stabilization of survivin in non-small cell lung cancer.
44. Innovative preclinical models for pulmonary drug delivery research
45. Human kallikrein-related peptidase 12 stimulates endothelial cell migration by remodeling the fibronectin matrix
46. Abnormal interleukin 10Ralpha expression contributes to the maintenance of elevated cyclooxygenase-2 in non-small cell lung cancer cells.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.